Lanzhang Granules Ameliorate Nonalcoholic Fatty Liver Disease by Regulating the PPAR<i>α</i> Signaling Pathway

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="6"><hr/></td></tr><tr class="thead"><td class="align_left">Antibody</td><td class="align_center">Company</td><td class="align_center">CAT</td><td class="align_center">Source</td><td class="align_center">MW(KDa)</td><td class="align_center">Dilution</td></tr><tr><td class="thead-hr" colspan="6"><hr/></td></tr><tr><td class="align_left"><i>β</i>-Actin</td><td class="align_center">CST</td><td class="align_center">4970</td><td class="align_center">Rabbit</td><td class="align_center">42</td><td class="align_center">1 : 1000</td></tr><tr><td class="align_left">ENHADH</td><td class="align_center">Abclonal</td><td class="align_center">A13488</td><td class="align_center">Rabbit</td><td class="align_center">79</td><td class="align_center">1 : 500</td></tr><tr><td class="align_left">ACOX1</td><td class="align_center">Proteintech</td><td class="align_center">10957-1-AP</td><td class="align_center">Rabbit</td><td class="align_center">74 (50)</td><td class="align_center">1 : 1000</td></tr><tr><td class="align_left">PPAR<i>α</i></td><td class="align_center">Proteintech</td><td class="align_center">15540-1-AP</td><td class="align_center">Rabbit</td><td class="align_center">52</td><td class="align_center">1 : 500</td></tr><tr class="table-tr"><td colspan="6"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The primary antibodies for Western blot.</div>

Evidence-Based Complementary and Alternative Medicine

tab2

Table 2

Table 2: Lanzhang Granules Ameliorate Nonalcoholic Fatty Liver Disease by Regulating the PPAR<i>α</i> Signaling Pathway 

Evidence-Based Complementary and Alternative Medicine

Lanzhang Granules Ameliorate Nonalcoholic Fatty Liver Disease by Regulating the PPARα Signaling Pathway

Table 2